Maeyouf, K.; Meewan, J.; Ali-Jerman, H.; Albatsh, M.; Somani, S.; Laskar, P.; Mullin, M.; Irving, C.; MacKenzie, G.; Dufès, C.
PEGylated Zein Micelles for Prostate Cancer Therapy: Influence of PEG Chain Length and Transferrin Targeting on Docetaxel Delivery. Pharmaceutics 2026, 18, 68.
https://doi.org/10.3390/pharmaceutics18010068
AMA Style
Maeyouf K, Meewan J, Ali-Jerman H, Albatsh M, Somani S, Laskar P, Mullin M, Irving C, MacKenzie G, Dufès C.
PEGylated Zein Micelles for Prostate Cancer Therapy: Influence of PEG Chain Length and Transferrin Targeting on Docetaxel Delivery. Pharmaceutics. 2026; 18(1):68.
https://doi.org/10.3390/pharmaceutics18010068
Chicago/Turabian Style
Maeyouf, Khadeejah, Jitkasem Meewan, Hawraa Ali-Jerman, Musa Albatsh, Sukrut Somani, Partha Laskar, Margaret Mullin, Craig Irving, Graeme MacKenzie, and Christine Dufès.
2026. "PEGylated Zein Micelles for Prostate Cancer Therapy: Influence of PEG Chain Length and Transferrin Targeting on Docetaxel Delivery" Pharmaceutics 18, no. 1: 68.
https://doi.org/10.3390/pharmaceutics18010068
APA Style
Maeyouf, K., Meewan, J., Ali-Jerman, H., Albatsh, M., Somani, S., Laskar, P., Mullin, M., Irving, C., MacKenzie, G., & Dufès, C.
(2026). PEGylated Zein Micelles for Prostate Cancer Therapy: Influence of PEG Chain Length and Transferrin Targeting on Docetaxel Delivery. Pharmaceutics, 18(1), 68.
https://doi.org/10.3390/pharmaceutics18010068